Taro Provides Results for September 30, 2021

Go back to Taro Provides Results for September 30, 2021

Taro Pharma (TARO) Misses Q2 EPS by 36c

October 28, 2021 5:16 PM EDT

Taro Pharma (NYSE: TARO) reported Q2 EPS of $0.66, $0.36 worse than the analyst estimate of $1.02. Revenue for the quarter came in at $132 million versus the consensus estimate of $153.23 million.

For earnings history and earnings-related data on Taro Pharma (TARO) click here.

... More